RepliCel Names Tom Kordyback Chief Financial Officer

RepliCel Names Tom Kordyback Chief Financial Officer

ID: 57781

(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 08/22/11 -- The Board of RepliCel Life Sciences Inc. (the "Company" or "RepliCel") (OTCBB: REPCF) today announced that it has appointed Tom Kordyback as its Chief Financial Officer, effective immediately. Mr. Kordyback takes over from Brent Petterson, whom the Board wishes to thank for his service to the Company. Mr. Petterson will remain on as a consultant to the Company as required.

Mr. Kordyback, CA, joins RepliCel with over 25 years of experience in corporate finance and management for emerging growth companies. He has held senior financial positions with Glenayre Electronics Inc. and Telelink Communications Inc. In 1995, he joined Creo Inc. as their Chief Financial Officer where he oversaw private financings totaling more than $80 million and led the company's Initial Public Offering on the NASDAQ stock exchange for $90 million. He remained at Creo until 2000; at which time, the company had over 4,000 employees worldwide.

Mr. Kordyback also served as a director and member of the Audit, Compensation and Merger and Acquisitions Committees for Extreme CCTV Inc., a developer and manufacturer of state-of-the-art surveillance systems listed on the TSX. In 2008, the company was sold to Bosch Security Systems, Inc. for CDN $93 million. Mr. Kordyback currently serves as director of Silver Sun Resources Corp., a public Canadian-based resource company.

"Mr. Kordyback has demonstrated the kind of superior business and financial acumen that makes him a perfect fit for RepliCel. His more than 25 years of experience leading private placements and public offerings aligns with the direction and the long-term goals of the Company," stated David Hall, President and CEO of RepliCel Life Sciences.

Mr. Kordyback is a Chartered Accountant and a member of the British Columbia Institute of Chartered Accountants.

On Behalf of the Board of Directors,

Peter Jensen, Chairman of the Board







Contacts:
RepliCel Life Sciences Inc.
Tammey George
Director of Communications
604-248-8730

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  No FDA Advisory Committee Meeting Planned in Connection With New Drug Application for CORLUX for Cushing's Syndrome 7th Annual Swedish-American Life Science Summit (SALSS) Draws Global Industry Attention to Stockholm From August 24th Through 26th
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 22.08.2011 - 13:00 Uhr
Sprache: Deutsch
News-ID 57781
Anzahl Zeichen: 0

contact information:
Town:

VANCOUVER, BRITISH COLUMBIA



Kategorie:

Biotech



Diese Pressemitteilung wurde bisher 191 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"RepliCel Names Tom Kordyback Chief Financial Officer"
steht unter der journalistisch-redaktionellen Verantwortung von

RepliCel Life Sciences Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

RepliCel CEO Provides 2017 Forecast ...

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/05/17 -- RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX VENTURE: RP) ("RepliCel" or the "Company"), a clinical-stage regenerative medicine company developing unique biologic pr ...

RepliCel Announces Debt Settlement ...

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/27/16 -- RepliCel Life Sciences Inc. (OTCQB: REPCD)(TSX VENTURE: RP)(FRANKFURT: P6P2) ("RepliCel" or the "Company"), a clinical-stage regenerative medicine company focused on th ...

Alle Meldungen von RepliCel Life Sciences Inc.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z